To deliver timely results that transform patient care pathways within clinical guidelines, helping clinicians to rule out infection and sepsis, while protecting the effectiveness of current antibiotics.

We help clinicians to save time, save lives and save money with a suite of game-changing assays designed to rule out infection before current methods, ensuring patients get appropriate care sooner.

Our assays focus on RNA-based host responses for earlier determination of infection status, based on unparalleled data sets.

Our unique clinical metadata is derived from around 150,000 samples and seven studies, using machine learning to extract insights and develop pioneering assays.